Pathogens co-transported with invasive non-native aquatic species: implications for risk analysis and legislation
Pathogens co-transported with invasive non-native aquatic species: implications for risk analysis and legislation
复制标题
DOI：
10.3897/neobiota.69.71358
复制
发表时间：
2021-10-18
期刊：
影响因子：
5.1
通讯作者：
Bass, David
中科院分区：
文献类型：
--
作者：
Foster, Rachel;Peeler, Edmund;Bass, David
入侵非本地物种（INNS）可以在外部和内部共同运输其他生物体，包括病毒，细菌和其他真核生物（包括后生动物寄生虫），统称为共生体。这些共生生物体包括病原体，其中一小部分受到监测和监管控制，但其中大多数目前未经审查和/或未知。这些腐殖型致病共生体可能对其他物种构成各种风险，对农业和水产养殖、野生动物/生态系统和人类健康（人畜共患疾病）的流行病学风险增加产生影响。已知病原体和其他致病性未知的共生体共同运输所产生的风险和影响在很大程度上仍未得到探索、立法，并且难以识别和量化。在这里，我们提出了一个工作流程，使用PubMed和谷歌学术系统地搜索现有的文献，以确定任何已知的和潜在的病原体的水生INNS。这一工作流程是评估INNS共转运病原体的性质和风险的先决条件;有必要更好地了解这一点，以便为政策和INNS风险评估提供信息。解决这一证据差距将有助于制定一套适当的法定责任，这些共生体，并支持新的和更有效的立法程序有关的疾病筛查和风险评估的INNS。
Invasive Non-Native Species (INNS) can co-transport externally and internally other organisms including viruses, bacteria and other eukaryotes (including metazoan parasites), collectively referred to as the symbiome. These symbiotic organisms include pathogens, a small minority of which are subject to surveillance and regulatory control, but most of which are currently unscrutinized and/or unknown. These putatively pathogenetic symbionts can potentially pose diverse risks to other species, with implications for increased epidemiological risk to agriculture and aquaculture, wildlife/ecosystems, and human health (zoonotic diseases). The risks and impacts arising from co-transported known pathogens and other symbionts of unknown pathogenic virulence, remain largely unexplored, unlegislated, and difficult to identify and quantify. Here, we propose a workflow using PubMed and Google Scholar to systematically search existing literature to determine any known and potential pathogens of aquatic INNS. This workflow acts as a prerequisite for assessing the nature and risk posed by co-transported pathogens of INNS; of which a better understanding is necessary to inform policy and INNS risk assessments. Addressing this evidence gap will be instrumental to devise an appropriate set of statutory responsibilities with respect to these symbionts, and to underpin new and more effective legislative processes relating to the disease screening and risk assessment of INNS.